More articles on executive moves: Roper St. Francis Healthcare names 1st physician CEOHCA East Florida school appoints new CEO: 4 notesNYC Health + Hospitals names interim CEOs of 2 hospitals.
Mr. Adcock took the helm Oct. 26. Dr. Soon-Shiong, the billionaire owner of the Los Angeles Times and creator of the cancer drug Abraxane, will become executive chair of the NantKwest board, according to the business, and is NantKwests biggest investor.
Kelly Gooch –
Tuesday, October 27th, 2020
© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.
” Im delighted to have Rich, with his extensive experience and unwavering dedication to innovation and operations, at the helm of NantKwest at an important time for the business and for the whole healthcare industry,” Dr. Soon-Shiong stated in a press release. “Not just is Rich distinctively certified to handle this function, but having actually worked with him for numerous years, I am positive that he is the ideal leader to advance NantKwest and its mission.”.
Mr. Adcock served as CEO of El Segundo, Calif.-based Verity Health, which declared Chapter 11 bankruptcy in 2018. 4 of Veritys healthcare facilities were offered out of bankruptcy this year, consisting of St. Vincent Medical Center in Los Angeles, which offered to Dr. Soon-Shiong in April..
© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.
Prior to signing up with Verity, Mr. Adcock was executive vice president and chief innovation officer of Sioux Falls, S.D.-based Sanford Health
NantKwest in Culver City, Calif., has actually chosen Richard Adcock to change Patrick Soon-Shiong, MD, as CEO, the biotech business said.